NCT06189898View on ClinicalTrials.gov

Functional Imaging to Identify Radiosensitive Esophageal Cancer - a Biomarker Validation Study

RecruitingOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

December 15, 2023

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions
Esophagus Cancer
Interventions
DIAGNOSTIC_TEST

Re Staging FDG-PET

Additional interim FDG-PET during week four of preoperative or definitive chemoradiation for esophageal carcinomas. Evaluation of standardized uptake ratio (SUR) and increased uptake of non tumor affected esophagus (Delta NTO).

Trial Locations (1)

13353

RECRUITING

Charité Universitätsmedizin Berlin, Berlin

All Listed Sponsors
collaborator

Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany

UNKNOWN

lead

Sebastian Zschaeck

OTHER